|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/28 | |
| C07K 16/30 | |||
| A61K 39/395 | |||
| C12P 21/08 | |||
| A61K 35/00 |
| (11) | Number of the document | 3156420 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16200557.3 |
| Date of filing the European patent application | 2011-12-06 | |
| (97) | Date of publication of the European application | 2017-04-19 |
| (45) | Date of publication and mention of the grant of the patent | 2019-02-20 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 420291 P | 2010-12-06 | US | |
| 201161446990 P | 2011-02-25 | US |
| (72) |
SMITH, Maria Leia, US
SUSSMAN, Django, US
ARTHUR, William, US
NESTEROVA, Albina, US
|
| (73) |
Seattle Genetics, Inc.,
21823 30th Drive, S.E., Bothell, WA 98021,
US
|
| (54) | HUMANIZED ANTIBODIES TO LIV-1 AND USE OF SAME TO TREAT CANCER |
| HUMANIZED ANTIBODIES TO LIV-1 AND USE OF SAME TO TREAT CANCER |